Level Four Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Level Four Advisory Services's JAZZ Position: Q2 2026 in Review
Level Four Advisory Services increased its Jazz Pharmaceuticals (JAZZ) stake by 0.55% in Q2 2026, buying an estimated $4.16K and bringing the position to 3,490 shares worth $841K. The position accounts for 0.02% of the portfolio, ranked #475.
Level Four Advisory Services first reported a position in JAZZ in Q4 2016 and has held it in 9 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Level Four Advisory Services held 3,490 shares of Jazz Pharmaceuticals worth $841K as of Q2 2026.
- Level Four Advisory Services bought 19 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.16K.
- Jazz Pharmaceuticals made up 0.02% of Level Four Advisory Services's portfolio in Q2 2026, its #475 holding.
- Level Four Advisory Services first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 9 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.